Nano1health
WitrynaNano1Health presents preliminary results on drug-resistance biomarkers in Leishmania infantum at London Calling 2024. London Calling 2024 poster We care, we innovate, … WitrynaRT @OIEAnimalHealth: Our 2024 Activity Report #OneHealthforAll, is OUT NOW! #COVID19 & #AntiMicrobialResistance are just two of the threats that have …
Nano1health
Did you know?
WitrynaSend us your question or query through this form and we will respond as soon as possible. WitrynaNano1Health - n1h 69 followers on LinkedIn. Real-time metagenomics for infection surveillance and genomic epidemiology from a One-Health approach Nano1Health is a knowledge-based company. We are scientists with cross-cutting expertise in genetics, epidemiology, infectious diseases, clinical diagnosis, and bioinformatics. We apply our …
WitrynaExtensive structural variation in the genome of Leishmania infantum Analyzing from small duplications to aneuploidies in the cloud Carrasco M, Ibañez M, Gómez M, Roura X, Ferrer L, Martí-Carreras J*, Francino O* Witryna1 kwi 2024 · Nano1Health will sequence the complete genome of Leishmania infantum isolates from different countries of the Mediterranean basin in the context of the …
Witryna18 lis 2024 · Olga Francino, CEO de Nano1Health. Neus Sabaté, investigadora ICREA de l'Institut de Microelectrònica de Barcelona (IMB-CNM CSIC) i fundadora de Fuelium i Sweanty. Elisabet del Valle, CEO d'Onalabs. Diana Marré, investigadora del Departament d'Antropologia Social i Cultural de la UAB i fundadora de l'spin-off Inari … WitrynaUnipharma, s.a. neix al 1970 i ja des dels seus inicis ha focalitzat el seu esforç en el desenvolupament de productes destinats al tractament i millora de patologies dermatològiques, àmbit que actualment compta amb un ampli reconeixement, sent un referent de la dermofarmàcia tant a nivell nacional com a l’exterior.
WitrynaNano1Health presents preliminary results on drug-resistance biomarkers in Leishmania infantum. The team of Nano1Health presents their preliminary results on discovery …
WitrynaN1 Health is an applied AI platform that solves the most complex challenges that healthcare business leaders face today. Drive engagement for every one. find my mobile service samsungWitryna15 lip 2024 · Fuelium, Onalabs i Nano1Health, totes tres de la xarxa del Parc de Recerca UAB, van ser premiades el passat dia 14 de juliol a la cerimònia anual de l’empresariat de Cerdanyola del Vallès. Fuelium va ser guardonada en la categoria d’internacionalització, Onalabs va ser reconeguda per la innovació i Nano1Health, … find my mobile service websiteWitrynaSoy una persona seria y responsable, aprovecho para presentar un poco mis ideas. Pienso que hay que ofrecer a los clientes garantía de satisfacción para fidelizar. Tengo experiencia de 20 años trabajando en equipo y es muy importante la cooperación y buen ambiente para poder solventar las incidencias y que siempre … find my mobile sonyWitrynaEl responsable del tratamiento es NANO1HEALTH, S.L., con NIF: B67615732 y tratará sus datos para responder a sus peticiones de contacto. También puede ser que … eric baysse cahorsWitrynaGenomic sequencing for early identification of Ebola virus remains a big challenge in low-income countries. Here, we report the complete genome sequence of an Ebola virus strain obtained during the 2024 Likati outbreak in the Democratic Republic of the Congo (DRC) by using the Oxford Nanopore Technologies (ONT) MinION sequencer. Otros … eric b danoffWitryna15 lut 2024 · Since February 1, 2024, NANO1HEALTH has moved into the UAB Research Park business incubator (Eureka Building, UAB Campus, Bellaterra, … eric bayreutherWitrynaReal-time metagenomics for infection surveillance and genomic epidemiology from a One-Health approach Nano1Health is a knowledge-based company. We are … eric b chesley